Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

NCT04335747 is registered in ClinicalTrials.gov with Salome Kristensen as lead sponsor.

NCT NCT04335747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases
Lead sponsor
Salome Kristensen
Phase
Observational
Overall status
Terminated
Start date
April 23, 2020
Completion date
July 1, 2021
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis, giant cell arteritis, psoriatic arthritis, rheumatoid arthritis, systemic lupus erythematosus